Henry, I am not good at reading tea leaves or g
Post# of 148175
(Total Views: 506)
Posted On: 10/15/2020 7:23:20 PM
Henry,
I am not good at reading tea leaves or guessing what the FDA will do. I would be rich were that the case.
However, I believe it profoundly unlikely that Dr. Seethamraju's comments are just
"an offhand remark from a physician who may not be fully aware of the trial protocol or the significance of invoking the FDA at this stage and simply meant to point out that the data is being evaluated"
Dr. Seethamraju initiated the push for leronlimab in covid (the "Hero" touted recurrently by NP).
Montefiore is one of the original sites for CD12, so there is quite literally ZERO CHANCE that he is not aware of the trial protocol.
From clinicaltrials.gov, CD12 trial sites include:
United States, New York
Montefiore Medical Center Recruiting
Bronx, New York, United States, 10467
Contact: Jane Wilson 718-920-7916
Principal Investigator: Harish Seethamraju, MD
I am not good at reading tea leaves or guessing what the FDA will do. I would be rich were that the case.
However, I believe it profoundly unlikely that Dr. Seethamraju's comments are just
"an offhand remark from a physician who may not be fully aware of the trial protocol or the significance of invoking the FDA at this stage and simply meant to point out that the data is being evaluated"
Dr. Seethamraju initiated the push for leronlimab in covid (the "Hero" touted recurrently by NP).
Montefiore is one of the original sites for CD12, so there is quite literally ZERO CHANCE that he is not aware of the trial protocol.
From clinicaltrials.gov, CD12 trial sites include:
United States, New York
Montefiore Medical Center Recruiting
Bronx, New York, United States, 10467
Contact: Jane Wilson 718-920-7916
Principal Investigator: Harish Seethamraju, MD
(6)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼